Drug intelligence / Profile preview

swine mycoplasma hyopneumoniae live vaccine

Development stage
Unknown
Lead developer
Jiangsu Academy of Agricultural Sciences
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Intranasal
01

Overview

Swine Mycoplasma live vaccine refers to a category of live attenuated vaccines designed to protect pigs against Enzootic Pneumonia, a chronic respiratory disease caused by *Mycoplasma hyopneumoniae*. These vaccines, most notably those utilizing the attenuated Strain 168 or RM48, are administered to piglets to induce both local mucosal immunity in the respiratory tract and systemic immune responses. Unlike traditional inactivated bacterins, live vaccines aim to colonize the upper respiratory tract, providing a more comprehensive immune barrier that reduces lung lesions and improves average daily gain in infected herds. While inactivated vaccines dominate the global market, live attenuated formulations are extensively utilized in the Chinese swine industry, often administered via intramuscular or intranasal routes.

Other names
Mycoplasma hyopneumoniae vaccine, liveM. hyo live vaccineswine mycoplasmal pneumonia live vaccineStrain 168 live vaccineStrain168 live vaccineStrain-168 live vaccine

Beyond the preview

Go deeper on swine mycoplasma hyopneumoniae live vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on swine mycoplasma hyopneumoniae live vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call